5-(5-acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one
C25H34N6O3 — CID 135491781
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(5-acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one
5-(5-acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one (PubChem CID 135491781) has the molecular formula C25H34N6O3 and a molecular weight of 466.59 g/mol. Its IUPAC name is 5-(5-acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one.
Molecular Properties
| Compound Name | 5-(5-acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one |
|---|---|
| PubChem CID | 135491781 |
| Molecular Formula | C25H34N6O3 |
| Molecular Weight | 466.59 g/mol |
| Exact Mass | 466.27 |
| IUPAC Name | 5-(5-acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one |
| SMILES | CCCCOc1ncc(C(C)=O)cc1-c1nc2c(CC)n(C3CCN(CC)CC3)nc2c(=O)[nH]1 |
| InChI | InChI=1S/C25H34N6O3/c1-5-8-13-34-25-19(14-17(15-26-25)16(4)32)23-27-21-20(6-2)31(29-22(21)24(33)28-23)18-9-11-30(7-3)12-10-18/h14-15,18H,5-13H2,1-4H3,(H,27,28,33) |
| InChIKey | NYWJLHDQEMYKGW-UHFFFAOYSA-N |
| XLogP | 3.78 |
| TPSA | 106.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.59 |
| LogP ≤ 5 | 3.78 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135491781 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.